Article ID Journal Published Year Pages File Type
11018156 Urologic Oncology: Seminars and Original Investigations 2018 8 Pages PDF
Abstract
Enzalutamide is less effective in patients with metastatic chemotherapy-naïve CRPC with Gleason scores ≥ 9, visceral metastasis, high NLR, and high ALP.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Oncology
Preview
Prognostic factors of oncologic outcomes in metastatic chemotherapy-naïve castration-resistant prostate cancer treated with enzalutamide in actual clinical practice in East Asia
Authors
, , , , , , , , , , , , , ,